The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development. This trial is open to subjects who have been diagnosed, or who have a suspicion of diagnosis based on imaging, with certain solid tumors. Subjects will have a blood sample collected at enrollment and provide medical history prior to initiation of treatment. There will be no further follow-up.
Due to inclement weather forecasted for Saturday, December 5, our TEWKSBURY drive-thru COVID-19 testing will be closing at noon.
Patients with appointments in the afternoon have been notified and rescheduled.
Keeping You Connected!
From newsletters to periodicals, there are a number of ways to stay up to date with Lowell General Hospital.